is liraglutide as effective as semaglutide vs. Wegovy vs Saxenda | Weight-loss

Approval status is night and day: tirzepatide is FDA-approved (Mounjaro in 2022, Zepbound in 2023), while retatrutide is still working through Phase 3

Agonist-induced internalisation of the glucagon-like peptide-1 receptor is mediated by the Gq pathway

Clinical data show that Reta can achieve up to 24% body-weight reduction per treatment course, positioning it as one of the most promising next-generation agents for metabolic programs

Here, we review evidence on GLP-1 RA use in people living with T2DM and CKD and summarize renal outcomes from clinical studies

Blood collection The 2ml blood sample was collected by venipuncture from the patients undergoing surgery for cataract on the same day